References
Brennan P, Davey-Smith G. Identifying novel causes of cancers to enhance cancer prevention: new strategies are needed. J Natl Cancer Inst. 2022;114:353–60.
Pfeifer GP, et al. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene. 2002;21:7435–51.
DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res. 2004;567:447–74.
Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999;91:1194–210.
Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994;54:4855–78.
Pleasance ED, et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature. 2010;463:184–90.
Imielinski M, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell. 2012;150:1107–20.
Alexandrov LB, et al. Mutational signatures associated with tobacco smoking in human cancer. Sci (80- ). 2016;354:618–22.
Yoshida K, et al. Tobacco smoking and somatic mutations in human bronchial epithelium. Nature. 2020;578:266–72.
Huang Z, et al. Single-cell analysis of somatic mutations in human bronchial epithelial cells in relation to aging and smoking. Nat Genet. 2022;54:492–8.
Duclos GE, et al. Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution. Sci Adv. 2019;5:1–12.
Kucab JE, et al. A compendium of mutational signatures of environmental agents. Cell. 2019;77:821–36.
Alexandrov LB, et al. The repertoire of mutational signatures in human cancer. Nature. 2020;578:94–101.
Scelo G, et al. Variation in genomic landscape of clear cell renal cell carcinoma across Europe. Nat Commun. 2014;5:5135.
Degasperi A, et al. Substitution mutational signatures in whole-genome–sequenced cancers in the UK population. Science. 2022;376:science.abl9283.
Ng SWK, et al. Convergent somatic mutations in metabolism genes in chronic liver disease. Nature. 2021;598:473–8.
Bolton KL, et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat Genet. 2020;52:1219–26.
Davey Smith G, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1–22.
Funding
The author is supported by a grant from the Wellcome Trust.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author has no conflict of interest interests to declare.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Campbell, P.J. Demystifying the black box: from ignorance to observation to mechanism in cancer research. Eur J Epidemiol 38, 1265–1267 (2023). https://doi.org/10.1007/s10654-022-00935-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-022-00935-9